These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 6790396)
41. Reduction of oxazepam to desmethyldiazepam by human intestinal bacteria. Okamura T; Sugiura W; Miyazawa M Biol Pharm Bull; 1996 Apr; 19(4):647-48. PubMed ID: 9132177 [TBL] [Abstract][Full Text] [Related]
42. Oxazepam, prazepam, and aggression in mice. Fox KA; Guerriero FJ; Zanghi DC Pharmacol Res Commun; 1974 Jun; 6(3):301-6. PubMed ID: 4473779 [No Abstract] [Full Text] [Related]
43. The pharmacokinetic profile of oxazepam. Alván G; Odar-Cederlöf I Acta Psychiatr Scand Suppl; 1978; (274):47-55. PubMed ID: 282777 [TBL] [Abstract][Full Text] [Related]
44. Prazepam metabolism in the rat. Viau JP; Epps JE; Di Carlo FJ J Pharm Sci; 1973 Apr; 62(4):641-5. PubMed ID: 4698988 [No Abstract] [Full Text] [Related]
45. Comparison of the effect of two prazepam formulations on psychomotor and cognitive function in healthy volunteers. Girre C; Bertaux L; Dussaucy E; Bonnet D; Palombo S; Fournier PE Int Clin Psychopharmacol; 1990 Jan; 5(1):57-64. PubMed ID: 2332608 [TBL] [Abstract][Full Text] [Related]
47. Comparison of sublingual and oral prazepam in normal subjects. I. Clinical data. Ansseau M; von Frenckell R; Jacqmin P Neuropsychobiology; 1987; 18(2):77-82. PubMed ID: 3330182 [TBL] [Abstract][Full Text] [Related]
48. [Studies on metabolism of prazepam. IV. Metabolic fate of prazepam in monkeys (author's transl)]. Kabuto S; Tamaki T; Koide T; Ishihama H Yakugaku Zasshi; 1978 Jul; 98(7):944-9. PubMed ID: 101652 [No Abstract] [Full Text] [Related]
49. Metabolism and pharmacokinetics of dothiepin. Maguire KP; Burrows GD; Norman TR; Scoggins BA Br J Clin Pharmacol; 1981 Sep; 12(3):405-9. PubMed ID: 7295471 [TBL] [Abstract][Full Text] [Related]
50. [Studies on metabolism of prazepam. I. Metabolic fate of prazepam in rats (author's transl)]. Ishihama H; Kabuto S; Kimata H; Tamaki T; Yonemitsu M Yakugaku Zasshi; 1978 Jun; 98(6):720-36. PubMed ID: 690811 [No Abstract] [Full Text] [Related]
51. Absorption and excretion of 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one (oxazepam) in humans. Determination of the drug by gas-liquid chromatography with electron capture detection. Knowles JA; Ruelius HW Arzneimittelforschung; 1972 Apr; 22(4):687-92. PubMed ID: 5068248 [No Abstract] [Full Text] [Related]
52. [Studies on metabolism of prazepam. III. Metabolic fate of cyclopropylmethyl group of prazepam in rats (author's transl)]. Ishihama H; Kimata H; Yonemitsu M; Matsumoto S; Ota T; Koga T; Otani G Yakugaku Zasshi; 1978 Jul; 98(7):937-43. PubMed ID: 712558 [No Abstract] [Full Text] [Related]
53. [Clinical pharmacology of procainamide and its active metabolite -N-acetylprocainamide]. Matusewicz W; Orszulak DE Przegl Lek; 1984; 41(5):379-83. PubMed ID: 6206523 [No Abstract] [Full Text] [Related]
54. Prazepam metabolism in vitro. Viau JP; Epps JE; Di Carlo FJ Biochem Pharmacol; 1972 Feb; 21(4):563-9. PubMed ID: 5014512 [No Abstract] [Full Text] [Related]
55. Significance of apparent half-lives of a metabolite with a higher elimination rate than its parent drug. Vree TB; Hekster CA; van der Kleijn E Drug Intell Clin Pharm; 1982 Feb; 16(2):126-31. PubMed ID: 7075463 [No Abstract] [Full Text] [Related]